FMS
Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an)
$21.58
-$0.06(-0.28%)
54
Overall
100
Value
20
Tech
44
Quality
Market Cap
$12.34B
Volume
677.46K
52W Range
$20.02 - $29.71
Target Price
$24.30
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $18.3B | $17.8B | $16.5B | $17.5B | $19.0B | $18.6B | $20.1B | $19.5B | $13.5B | $13.1B | ||
| Total Revenue | $18.3B | $17.8B | $16.5B | $17.5B | $17.9B | $17.6B | $19.4B | $19.5B | $19.3B | $19.6B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-10.7B | $-11.8B | $-11.4B | $-12.1B | $-12.3B | $12.8B | $14.5B | $14.5B | $14.6B | $14.6B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $5.8B | $6.0B | $5.2B | $5.4B | $5.5B | $4.8B | $4.9B | $4.9B | $4.8B | $5.0B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $3.2B | $14.1B | $13.7B | $3.2B | $3.7B | $3.3B | $4.0B | $3.9B | $4.3B | $3.9B | ||
| Research & Development | $162.4M | $130.7M | $133.6M | $168.0M | $193.8M | $220.8M | $228.6M | $232.0M | $183.5M | $158.0M | ||
| Research Expense | $162.4M | $130.7M | $133.6M | $168.0M | $193.8M | $220.8M | $228.6M | -- | $183.5M | $158.0M | ||
| Selling, General & Administrative | $3.0B | $13.9B | $12.8B | $3.1B | $3.5B | $3.1B | $3.8B | $3.5B | $3.1B | $3.0B | ||
| Selling & Marketing Expenses | $3.0B | $3.6B | $2.9B | $3.1B | $3.5B | $3.1B | $3.8B | $808.0M | $3.1B | $3.0B | ||
| General & Administrative Expenses | -- | $10.4B | $9.9B | -- | -- | -- | -- | $2.7B | $2.8B | -- | ||
| Salaries & Wages | $-69.9M | $-6.9B | $809.0M | $-28.8M | $-30.8M | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-775.9M | $-735.5M | $724.8M | $-1.6B | $-1.6B | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-775.9M | $-622.7M | $724.8M | $-1.6B | $-1.6B | -- | -- | -- | -- | -- | ||
| Amortization | $-149.2M | $-112.8M | $-70.7M | $-135.5M | $-144.7M | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | $-400.0M | -- | -- | $-28.8M | -- | -- | -- | $177.2M | $932.9M | $720.7M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $3.0B | $2.3B | $1.3B | $2.2B | $3.0B | $2.7B | $2.0B | $998.7M | $497.4M | $1.1B | ||
| EBITDA | $3.1B | $2.7B | $3.8B | $3.4B | $4.1B | $3.5B | $3.4B | $2.2B | $3.2B | $3.4B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $452.2M | -- | $301.1M | $-486.0M | $410.0M | $353.6M | $360.1M | $424.6M | $407.0M | $384.4M | ||
| Interest Income Operating | -- | -- | -- | -- | $1.2B | -- | -- | -- | -- | -- | ||
| Intinc | $46.6M | $43.3M | $-147.4M | $61.6M | $42.0M | $73.2M | $67.7M | $88.2M | $71.6M | $69.6M | ||
| Net Non-Operating Interest Income/Expense | $-405.5M | $43.3M | $-147.4M | $61.6M | $42.0M | $73.2M | $292.5M | $-336.4M | $-335.5M | $-314.8M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | -- | $14.7M | -- | -- | ||
| Other Income/Expense | $64.9M | $330.0M | $-1.9B | $-73.7M | $-94.5M | $-92.2M | $57.0M | $63.7M | $-895.0M | $-709.5M | ||
| Other Special Charges | -- | $657.1M | $-296.3M | $2.2B | $251.7M | $324.8M | $-10.5M | $-122.4M | $760.1M | $528.1M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | $1.3B | $17.0M | $42.3M | $-410.0M | $-353.6M | -- | -- | -- | -- | ||
| Impairment of Capital Assets | -- | -- | $-17.0M | $-42.3M | $410.0M | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $2.3B | $2.0B | $3.0B | $1.8B | $2.3B | $1.9B | $1.6B | $427.2M | $1.5B | $1.9B | ||
| Pre-Tax Income | $2.2B | $2.0B | $2.7B | $1.8B | $1.9B | $1.6B | $1.2B | $2.5M | $1.1B | $1.5B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $683.1M | $454.0M | $511.1M | $401.6M | $500.6M | $352.8M | $325.0M | $300.6M | $316.1M | $321.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $2.0B | $3.1B | $2.4B | $2.9B | $1.2B | $969.3M | $673.4M | $-531.5M | $537.9M | $978.4M | ||
| Net Income (Continuing Operations) | $2.0B | $3.1B | $2.4B | $2.9B | $2.9B | $2.4B | $894.3M | $-298.0M | $740.9M | $1.2B | ||
| Net Income (Discontinued Operations) | $2.0B | $3.1B | $2.4B | $2.9B | $1.2B | $969.3M | $673.4M | $-531.5M | $537.9M | $978.4M | ||
| Net Income (Common Stockholders) | $2.0B | $3.1B | $2.4B | $2.9B | $1.2B | $969.3M | $673.4M | $-531.5M | $537.9M | $978.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | $64.9M | $1.0B | $1.5B | ||
| TOTALS | ||||||||||||
| Total Expenses | $-7.5B | $2.3B | $2.3B | $-8.9B | $-8.6B | $-9.2B | $17.9B | $18.5B | $18.8B | $18.5B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $611.5M | $613.1M | $613.1B | $605.4M | $588.1M | $1.5B | $1.6B | $586.8M | $586.8M | -- | ||
| Average Shares Outstanding (Diluted) | $612.5M | $1.5B | $741.6M | $847.2M | $1.5B | $1.5B | $1.6B | $586.8M | $586.8M | -- | ||
| Shares Outstanding | $306.2M | $306.5M | $306.9M | $298.3M | $292.9M | $293.0M | $293.4M | $558.6M | $558.6M | $293.4M | ||
| Basic EPS | $2.04 | $2.08 | $3.23 | $1.98 | $1.98 | $1.66 | $1.15 | $0.85 | $0.92 | -- | ||
| Basic EPS (Continuing Operations) | $2.04 | $2.08 | $3.23 | $1.98 | $1.98 | $1.66 | $1.15 | $0.85 | $0.92 | -- | ||
| Diluted EPS | $2.03 | $2.08 | $3.23 | $1.98 | $1.98 | $1.66 | $1.15 | $0.85 | $0.92 | -- | ||
| Diluted EPS (Continuing Operations) | $2.03 | $2.08 | $3.23 | $1.98 | $1.98 | $1.66 | $1.15 | $0.85 | $0.92 | -- | ||
| Dividend Per Share | $0.80 | -- | -- | -- | -- | -- | -- | $0.59 | $0.72 | -- | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | -- | $1.3B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $-64.9M | $67.2M | $-73.3M | $73.7M | $94.5M | $92.2M | $66.6M | $121.8M | $134.9M | $181.4M | ||
| Earnings From Equity Interest Net Of Tax | $-64.9M | $67.2M | $-73.3M | $73.7M | $94.5M | $92.2M | $66.6M | $121.8M | $134.9M | $181.4M | ||
| Gain On Sale Of Business | $-54.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | $148.2M | $-63.0M | $14.7M | -- | ||
| Interest Expense Operating | $-387.1M | -- | -- | $491.1M | $368.0M | -- | -- | -- | -- | -- | ||
| Marketing Expense | -- | -- | -- | -- | $410.0M | -- | -- | -- | -- | -- | ||
| Minority Interests | $-305.6M | $274.7M | $243.7M | $238.9M | $-271.5M | $-249.7M | $-220.9M | $-233.5M | $-203.0M | $-212.9M | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | $353.6M | -- | -- | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | -- | -- | $14.5B | $14.6B | $14.6B | ||
| Other Gand A | -- | $10.4B | $9.9B | -- | -- | -- | -- | $2.7B | $2.8B | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $353.6M | -- | -- | -- | -- | ||
| Realized Capital Gain | -- | -- | $2.0B | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | -- | $10.4B | $9.9B | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $3.0B | $3.6B | $2.9B | $3.1B | $3.1B | $3.1B | $3.8B | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FMS | $21.58 | -0.3% | 677.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW